Ironwood Pharmaceuticals, Inc. (IRWD)
4.82
-0.03
(-0.62%)
USD |
NASDAQ |
Nov 13, 16:00
4.82
0.00 (0.00%)
After-Hours: 19:59
Ironwood Pharmaceuticals Market Cap : 797.95M for Nov. 13, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 12, 2026 | 802.92M |
| November 11, 2026 | 806.23M |
| November 10, 2026 | 796.30M |
| November 09, 2026 | 774.78M |
| November 06, 2026 | 726.77M |
| November 05, 2026 | 667.17M |
| November 04, 2026 | 624.13M |
| November 03, 2026 | 579.43M |
| November 02, 2026 | 571.73M |
| October 30, 2026 | 578.34M |
| October 29, 2026 | 598.17M |
| October 28, 2026 | 596.52M |
| October 27, 2026 | 579.99M |
| October 26, 2026 | 578.34M |
| October 23, 2026 | 571.73M |
| October 22, 2026 | 589.91M |
| October 21, 2026 | 586.60M |
| October 20, 2026 | 599.82M |
| October 19, 2026 | 588.25M |
| October 16, 2026 | 578.34M |
| October 15, 2026 | 622.95M |
| October 14, 2026 | 594.86M |
| October 13, 2026 | 593.21M |
| October 12, 2026 | 621.30M |
| October 09, 2026 | 631.22M |
| Date | Value |
|---|---|
| October 08, 2026 | 639.48M |
| October 07, 2026 | 619.65M |
| October 06, 2026 | 599.82M |
| October 05, 2026 | 603.13M |
| October 02, 2026 | 601.47M |
| October 01, 2026 | 621.30M |
| September 30, 2026 | 656.00M |
| September 29, 2026 | 687.40M |
| September 28, 2026 | 680.79M |
| September 25, 2026 | 682.44M |
| September 24, 2026 | 692.36M |
| September 23, 2026 | 705.57M |
| September 22, 2026 | 747.71M |
| September 21, 2026 | 728.71M |
| September 18, 2026 | 720.45M |
| September 17, 2026 | 698.96M |
| September 16, 2026 | 689.05M |
| September 15, 2026 | 670.87M |
| September 14, 2026 | 689.05M |
| September 11, 2026 | 674.18M |
| September 10, 2026 | 656.00M |
| September 09, 2026 | 672.53M |
| September 08, 2026 | 689.05M |
| September 04, 2026 | 703.92M |
| September 03, 2026 | 708.88M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Xencor, Inc. | 2.772B |
| Viking Therapeutics, Inc. | 3.726B |
| IDEAYA Biosciences, Inc. | 3.073B |
| BioMarin Pharmaceutical, Inc. | 11.08B |
| Inovio Pharmaceuticals, Inc. | 158.11M |
Market Cap Related Metrics
| PE Ratio | 5.396 |
| PS Ratio | 2.000 |
| PEG Ratio | 0.0107 |
| Price to Free Cash Flow | 3.899 |
| Price | 4.82 |
| Earnings Yield | 18.53% |
| PEGY Ratio | 0.0107 |
| Operating PE Ratio | 3.183 |
| Normalized PE Ratio | 5.404 |